Novel antiviral activity of bromocriptine against dengue virus replication

Antiviral Research

Volumn 131, Issue , 2016, Pages 141-147

  Kato, Fumihiro ^a,b   Ishida, Yuki ^a   Oishi, Shinya ^a   Fujii, Nobutaka ^a   Watanabe, Satoru ^c   Vasudevan, Subhash G ^c   Tajima, Shigeru ^b   Takasaki, Tomohiko ^b   Suzuki, Youichi ^d   Ichiyama, Koji ^d   Yamamoto, Naoki ^d   Yoshii, Kentaro ^e   Takashima, Ikuo ^e   Kobayashi, Takeshi ^a   Miura, Tomoyuki ^a   Igarashi, Tatsuhiko ^a   Hishiki, Takayuki ^a,f  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e HOKKAIDO UNIVERSITY   (Japan)

^f TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Antiviral drug; Bromocriptine; Dengue virus; Focus assay; Replicon; Time of drug addition

Indexed keywords

ANTIVIRUS AGENT; BROMOCRIPTINE; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; NONSTRUCTURAL PROTEIN 4B; NONSTRUCTURAL PROTEIN 5A; QUINPIROLE; ROTIGOTINE; VIRUS RNA;

AGMK CELL LINE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIVIRAL ACTIVITY; ANTIVIRAL RESISTANCE; ARTICLE; BHK CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG ELIMINATION; EC50; HUMAN; HUMAN CELL; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; REPLICON; RNA REPLICATION; VIRUS ATTACHMENT; VIRUS ISOLATION; VIRUS REPLICATION; DRUG EFFECTS; PHYSIOLOGY; VIRAL PLAQUE ASSAY;

ANTIVIRAL AGENTS; BROMOCRIPTINE; DENGUE; DENGUE VIRUS; DRUG RESISTANCE, VIRAL; HUMANS; REPLICON; VIRAL PLAQUE ASSAY; VIRUS REPLICATION;

EID: 84971265339     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2016.04.014     Document Type: Article

References (39)

1. S. Aguirre, A.M. Maestre, S. Pagni, J.R. Patel, T. Savage, D. Gutman, K. Maringer, D. Bernal-Rubio, R.S. Shabman, V. Simon, J.R. Rodriguez-Madoz, L.C. Mulder, G.N. Barber, and A. Fernandez-Sesma DENV inhibits type I IFN production in infected cells by cleaving human STING PLoS Pathog. 8 2012 e1002934
2. T.J. Chambers, C.S. Hahn, R. Galler, and C.M. Rice Flavivirus genome organization, expression, and replication Annu. Rev. Microbiol. 44 1990 649 688
3. K.W. Chan, S. Watanabe, R. Kavishna, S. Alonso, and S.G. Vasudevan Animal models for studying dengue pathogenesis and therapy Antivir. Res. 123 2015 5 14
4. C.J. Chen, M.D. Kuo, L.J. Chien, S.L. Hsu, Y.M. Wang, and J.H. Lin RNA-protein interactions: involvement of NS3, NS5, and 3′ noncoding regions of Japanese encephalitis virus genomic RNA J. Virol. 71 1997 3466 3473
5. V. Fernandez-Duenas, M. Gomez-Soler, K.A. Jacobson, S.T. Kumar, K. Fuxe, D.O. Borroto-Escuela, and F. Ciruela Molecular determinants of A2AR-D2R allosterism: role of the intracellular loop 3 of the D2R J. Neurochem. 123 2012 373 384
6. M. Geurts, E. Hermans, J. Cumps, and J.M. Maloteaux Dopamine receptor-modulated [35S]GTPgammaS binding in striatum of 6-hydroxydopamine-lesioned rats Brain Res. 841 1999 135 142
7. O.J. Ginther, V.G. Santos, R.A. Mir, and M.A. Beg Role of LH in the progesterone increase during the bromocriptine-induced prolactin decrease in heifers Theriogenology 78 2012 1969 1976
8. D.J. Gubler Dengue and dengue hemorrhagic fever Clin. Microbiol. Rev. 11 1998 480 496
9. N.S. Heaton, R. Perera, K.L. Berger, S. Khadka, D.J. Lacount, R.J. Kuhn, and G. Randall Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis Proc. Natl. Acad. Sci. U. S. A. 107 2010 17345 17350
10. M. Ito, K. Yamada, T. Takasaki, B. Pandey, R. Nerome, S. Tajima, K. Morita, and I. Kurane Phylogenetic analysis of dengue viruses isolated from imported dengue patients: possible aid for determining the countries where infections occurred J. Travel Med. 14 2007 233 244
11. M. Kapoor, L. Zhang, M. Ramachandra, J. Kusukawa, K.E. Ebner, and R. Padmanabhan Association between NS3 and NS5 proteins of dengue virus type 2 in the putative RNA replicase is linked to differential phosphorylation of NS5 J. Biol. Chem. 270 1995 19100 19106
12. F. Kato, T. Kobayashi, S. Tajima, T. Takasaki, T. Miura, T. Igarashi, and T. Hishiki Development of a novel Dengue-1 virus replicon system expressing secretory Gaussia luciferase for analysis of viral replication and discovery of antiviral drugs Jpn. J. Infect. Dis. 67 2014 209 212
13. S. Khadka, A.D. Vangeloff, C. Zhang, P. Siddavatam, N.S. Heaton, L. Wang, R. Sengupta, S. Sahasrabudhe, G. Randall, M. Gribskov, R.J. Kuhn, R. Perera, and D.J. LaCount A physical interaction network of dengue virus and human proteins Mol. Cell. Proteom. MCP 10 2011 M111 012187
14. S.P. Lim, Q.Y. Wang, C.G. Noble, Y.L. Chen, H. Dong, B. Zou, F. Yokokawa, S. Nilar, P. Smith, D. Beer, J. Lescar, and P.Y. Shi Ten years of dengue drug discovery: progress and prospects Antivir. Res. 100 2013 500 519
15. B.D. Lindenbach, H.-J. Thiel, and C.M. Rice Flaviviridae: the Viruses and Their Replication fifth ed. 2007 Lippincott-Raven Publishers
16. D. Luo, S.G. Vasudevan, and J. Lescar The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development Antivir. Res. 118 2015 148 158
17. C.G. Noble, Y.L. Chen, H. Dong, F. Gu, S.P. Lim, W. Schul, Q.Y. Wang, and P.Y. Shi Strategies for development of Dengue virus inhibitors Antivir. Res. 85 2010 450 462
18. T. Omatsu, M.L. Moi, T. Hirayama, T. Takasaki, S. Nakamura, S. Tajima, M. Ito, T. Yoshida, A. Saito, Y. Katakai, H. Akari, and I. Kurane Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity J. General Virol. 92 2011 2272 2280
19. S. Perachon, J.C. Schwartz, and P. Sokoloff Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors Eur. J. Pharmacol. 366 1999 293 300
20. M. Qing, F. Yang, B. Zhang, G. Zou, J.M. Robida, Z. Yuan, H. Tang, and P.Y. Shi Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein Antimicrob. Agents Chemother. 53 2009 3226 3235
21. L.J. Reed, and H. Muench A simple method of estimating fifty percent endpoints Am. J. Hyg. 27 1938 493 497
22. D. Scheller, C. Ullmer, R. Berkels, M. Gwarek, and H. Lubbert The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease Naunyn-Schmiedeberg's Arch. Pharmacol. 379 2009 73 86
23. C.P. Simmons, J.J. Farrar, V. Nguyen, and B. Wills Dengue N. Engl. J. Med. 366 2012 1423 1432
24. S. Tajima, Y. Nukui, M. Ito, T. Takasaki, and I. Kurane Nineteen nucleotides in the variable region of 3′ non-translated region are dispensable for the replication of dengue type 1 virus in vitro Virus Res. 116 2006 38 44
25. H. Takahashi, C. Takahashi, N.J. Moreland, Y.T. Chang, T. Sawasaki, A. Ryo, S.G. Vasudevan, Y. Suzuki, and N. Yamamoto Establishment of a robust dengue virus NS3-NS5 binding assay for identification of protein-protein interaction inhibitors Antivir. Res. 96 2012 305 314
26. I. Takashima, K. Morita, M. Chiba, D. Hayasaka, T. Sato, C. Takezawa, A. Igarashi, H. Kariwa, K. Yoshimatsu, J. Arikawa, and N. Hashimoto A case of tick-borne encephalitis in Japan and isolation of the the virus J. Clin. Microbiol. 35 1997 1943 1947
27. M.Y. Tay, W.G. Saw, Y. Zhao, K.W. Chan, D. Singh, Y. Chong, J.K. Forwood, E.E. Ooi, G. Gruber, J. Lescar, D. Luo, and S.G. Vasudevan The C-terminal 50 amino acid residues of dengue NS3 protein are important for NS3-NS5 interaction and viral replication J. Biol. Chem. 290 2015 2379 2394
28. I. Umareddy, A. Chao, A. Sampath, F. Gu, and S.G. Vasudevan Dengue virus NS4B interacts with NS3 and dissociates it from single-stranded RNA J. General Virol. 87 2006 2605 2614
29. K.W. van Cleef, G.J. Overheul, M.C. Thomassen, S.J. Kaptein, A.D. Davidson, M. Jacobs, J. Neyts, F.J. van Kuppeveld, and R.P. van Rij Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication Antivir. Res. 99 2013 165 171
30. M. Velasco, and A. Luchsinger Dopamine: pharmacologic and therapeutic aspects Am. J. Ther. 5 1998 37 43
31. Q.Y. Wang, H. Dong, B. Zou, R. Karuna, K.F. Wan, J. Zou, A. Susila, A. Yip, C. Shan, K.L. Yeo, H. Xu, M. Ding, W.L. Chan, F. Gu, P.G. Seah, W. Liu, S.B. Lakshminarayana, C. Kang, J. Lescar, F. Blasco, P.W. Smith, and P.Y. Shi Discovery of dengue virus NS4B inhibitors J. Virol. 89 2015 8233 8244
32. Q.Y. Wang, R.R. Kondreddi, X. Xie, R. Rao, S. Nilar, H.Y. Xu, M. Qing, D. Chang, H. Dong, F. Yokokawa, S.B. Lakshminarayana, A. Goh, W. Schul, L. Kramer, T.H. Keller, and P.Y. Shi A translation inhibitor that suppresses dengue virus in vitro and in vivo Antimicrob. Agents Chemother. 55 2011 4072 4080
33. S. Watanabe, A.P. Rathore, C. Sung, F. Lu, Y.M. Khoo, J. Connolly, J. Low, E.E. Ooi, H.S. Lee, and S.G. Vasudevan Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial Antivir. Res. 96 2012 32 35
34. WHO Dengue Control 2013
35. C.C. Yang, H.S. Hu, R.H. Wu, S.H. Wu, S.J. Lee, W.T. Jiaang, J.H. Chern, Z.S. Huang, H.N. Wu, C.M. Chang, and A. Yueh A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease Antimicrob. Agents Chemother. 58 2014 110 119
36. Y. Zhang, P.W. Scislowski, R. Prevelige, S. Phaneuf, and A.H. Cincotta Bromocriptine/SKF38393 treatment ameliorates dyslipidemia in ob/ob mice Metab. Clin. Exp. 48 1999 1033 1040
37. G. Zou, Y.L. Chen, H. Dong, C.C. Lim, L.J. Yap, Y.H. Yau, S.G. Shochat, J. Lescar, and P.Y. Shi Functional analysis of two cavities in flavivirus NS5 polymerase J. Biol. Chem. 286 2011 14362 14372
38. G. Zou, H.Y. Xu, M. Qing, Q.Y. Wang, and P.Y. Shi Development and characterization of a stable luciferase dengue virus for high-throughput screening Antivir. Res. 91 2011 11 19
39. J. Zou, T. Lee le, Q.Y. Wang, X. Xie, S. Lu, Y.H. Yau, Z. Yuan, S. Geifman Shochat, C. Kang, J. Lescar, and P.Y. Shi Mapping the Interactions between the NS4B and NS3 proteins of dengue virus J. Virol. 89 2015 3471 3483